Recent Updates
Recently added Catalysts
PLRX Positive Sentiment

Pliant Therapeutics to Participate in the 41st Annual J.P. Morgan Healthcare Conference

Tuesday, January 3, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Pliant Therapeutics, Inc. (Nasdaq: PLRX) announced its participation in the 41st Annual J.P. Morgan Healthcare Conference, where CEO Bernard Coulie will deliver an update. The conference is scheduled from January 9-12, 2023, with Pliant's presentation set for January 10 at 7:30 a.m. PT. Interested parties can access the presentation through the company's Investor Relations page, enhancing transparency for stakeholders.
Price reaction · baseline $19.33 (2022-12-30 close) · hit after-hours · clean, no other PLRX news in the window
day 0 close · peak
-1.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a prestigious healthcare conference indicates industry recognition.
  • The CEO's presentation suggests a proactive approach in company updates.
  • Availability of the presentation to a wide audience promotes transparency.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+47%
120-day peak, hindsight
Typical move
1.5%
average across 6 past catalysts
Cash runway
~37 mo
Minimal dilution risk
Lead asset
PLN-101095
Phase 1 · Advanced or Metastatic Solid Tumor

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced that Bernard Coulie, M.D., Ph.D., President and Chief Executive Officer of Pliant, will present a company update as part of the 41st Annual J.P. Morgan Healthcare Conference.
41st Annual J.P. Morgan Healthcare Conference (January 9-12, 2023)
Presentation Date/Time: January 10, 2023, at 7:30 a.m. PT/ 10:30 a.m. ET
Venue: Elizabethan Room D The Westin St. Francis San Francisco San Francisco, California
Interested parties can access the company presentation from the Investor Relations’ Events & Presentation page of Pliant’s website at https://ir.pliantrx.com/news-and-events/events-and-presentations with an audio archive available for 30 days from the time it is made available.
About Pliant Therapeutics, Inc.
Investor and Media Contact:
Vice President, Investor Relations and Corporate Communications
Pliant Therapeutics, Inc.

Frequently Asked Questions

When is Pliant Therapeutics presenting at the J.P. Morgan Conference?

Pliant Therapeutics will present on January 10, 2023, at 7:30 a.m. PT.

Where is the 41st Annual J.P. Morgan Healthcare Conference held?

The conference takes place at The Westin St. Francis in San Francisco, California.

Who will present at the J.P. Morgan Conference for Pliant?

Bernard Coulie, M.D., Ph.D., will present a company update for Pliant.

How long will the presentation audio be available?

The audio archive of the presentation will be accessible for 30 days.

Where can I find Pliant's investor presentation?

You can access the presentation on Pliant's Investor Relations events page.

ShareAdd on Google
Tags: PLRX Viatris Investor Conferences Healthcare Pliant Therapeutics fIbrosis J.P. Morgan healthcare conference clinical stage biotech
Last updated: Jan 3, 2023

Biotech snapshot

Cash runway
$158M liquidity · $4M/mo burn
~37 mo
Minimal dilution risk
Lead asset
PLN-101095Phase 1
Advanced or Metastatic Solid Tumor →

Catalyst track record

+47%
best trade around PLRX's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for PLRX.

See every catalyst's timing & PoA →